Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial

TNM Classification of Malignant Tumors

1998 • 5,989 citations

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

1994 • 1,108 citations

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

1994 • 921 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide

1985 • 251 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.

1980 • 135 citations

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

1990 • 133 citations

Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes.

1993 • 122 citations

Cutaneous Melanoma

1986 • 122 citations

A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma

1995 • 121 citations

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1992 • 89 citations

Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma

1991 • 76 citations

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.

1991 • 76 citations

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma

1987 • 69 citations

A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates

1986 • 65 citations

A new approach in specific, active immunotherapy

1977 • 63 citations

Positive Relationship of Clinical and Serologic Responses to Vaccinia Melanoma Oncolysate

1987 • 55 citations

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

1992 • 48 citations

Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma

1992 • 47 citations

Active specific immunotherapy in malignant melanoma

1989 • 41 citations

A preliminary trial of vaccinia oncolysates in the treatment of recurrent melanoma with serologic responses to the treatment.

1983 • 28 citations

Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates.

1984 • 26 citations

Specific tumor immunity produced by the injection of vaccinia viral oncolysates

1982 • 10 citations